Resection and Immunotherapy for Recurrent Grade III Glioma
Table 1
Patient characteristics.
AA
AOD
AOA
patients
18
13
8
Male/female (%)
10 (55)/8 (45)
9 (69)/4 (31)
7 (88)/1 (12)
Registration period
2004–2010
2004–2009
2002–2010
Median age (range)
30 (7–62)
42 (38–69)
32 (11–56)
Median events*
2
3
2
1 event/>1 event (%)
9 (50)/9 (50)
5 (38)/8 (62)
5 (63)/3 (37)
Total/subtotal resection (%)
11 (61)/7 (39)
3 (23)/10 (77)
3 (37)/5 (63)
Initial grade III/dedifferentiation (%)
17 (94)/1 (6)
8 (62)/5 (38)
3 (37)/5 (63)
Patients alive (%)
7 (38)
7 (53)
2 (25)
AA: anaplastic astrocytoma; AOD: anaplastic oligodendroglioma; AOA: anaplastic oligoastrocytoma.
*: number of events prior to surgery and immunotherapy.
